At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 39 enrolled
Drug / intervention
cefprozil +1 moredrug
Likely dose
cefprozil 500 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Relative Bioavailability Study of Cefprozil 500 mg Tablets Under Non-Fasting Conditions
In Brief
A Phase 1 clinical trial evaluating cefprozil and Cefzil® for Healthy. Completed, enrolled 39 participants across 1 site.
Detailed Summary
The objective of this study is to compare the relative bioavailability of cefprozil 500 mg tablets with that of Cefzil 500 mg tablets in healthy, non-smoking adults under non-fasting conditions.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
Collaborators--
Timeline
Phase 1CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 2003
Primary CompletionSep 2003
First PostedFeb 2009
TodayJul 2026
First PostedFeb 10, 2009
Enrollment StartSep 1, 2003
Primary CompletionSep 1, 2003
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 17.4 years ago
Interventions
cefprozildrug
500 mg Tablet
Cefzil®drug
500 mg Tablet